ShareProphets : tidm

RPI

Raspberry Pi (#RPI) – “appointment of Tim Powell as Chief Financial Officer… with effect from 16 October”

2026-07-06 06:27:32

Raspberry Pi (#RPI) – “profitability materially ahead of the comparable period”, expects FY EBITDA “significantly ahead of current market expectations”

2026-06-05 06:36:56

Raspberry Pi (#RPI) – 2025 adj. EPS up to $0.1448, “sales momentum has carried into the opening months of this year”

2026-03-31 06:39:29

Raspberry Pi – 2025 “ahead of market consensus forecasts”, but what about the current year?…

UK computing technology company Raspberry Pi (RPI) has issued a “Year-end Trading Update” including that “it expects adjusted FY2025 EBITDA to be ahead of market consensus forecasts, at not less than $45m, up over 20% on FY2024… Net cash was $28m at year end”. So what about a share price response to 283.8p, a few percent down?

By Steve Moore | Published 2026-01-14 08:04:57 |

Raspberry Pi (#RPI) – expects 2025 adj. EBITDA “not less than $45m, up over 20%” though notes DRAM pricing “has increased rapidly in recent months”

2026-01-13 07:43:59

Raspberry Pi (#RPI) – CFO Richard Boult “to step down… so that he can explore new challenges”

2025-10-31 07:42:56

Raspberry Pi (#RPI) – H1 adj. EPS down to $0.0476, argues “volumes are expected to be higher in the second half”

2025-09-23 06:54:05

Raspberry Pi (#RPI) – 2024 adj. EPS down to $0.107, “with channel inventory now normalised… anticipates a steady build-up in demand”

2025-04-02 06:29:51

Raspberry Pi (#RPI) – expects 2024 adj. EBITDA “not less than $36m”, 2025 “expects demand to build gradually through the year”

2025-01-29 07:41:52

Raspberry Pi (#RPI) – admission to trading on London Stock Exchange

2024-06-14 06:57:29

previous 0 Page 1 of 1 (10 articles) next 0

Latest News

Show All

UPDATED: Lucian Miers & Jim Mellon are coming back to Sharestock in 2027: early bird tickets now on sale, event 15% sold out!

Tom Winnifrith Bearcast: the Sydney Sweeney row with the Mrs and daughter 2

Evil Banksta weighs in on TekCapital after today’s spooftastic RNS

Good news travels fast but bad news….the case of Skinbiotherapeutics

Mothercare: the end is nigh, don’t blame Trump, I told y’all eons ago

EXPOSE: Nuburu shares in a slump post relisting on American Stock Exchange and latest accounts contain a material error

Letter to Pointon Young, former auditors to Amazing AI

Reinvesting my Satsuma Winnings

Tribal Group – “Proposed Acquisition by Main Capital Partners” provides us with another share tip winner

Quantum Data Energy - why are its shares still suspended?

Recent Comments

TOM18 Sep 2026

a shareholder could call a meeting to propose new directors by PM & pals own 50% of the equity sod vote it down

Letter to Pointon Young, former auditors to Amazing AI

AIMINVESTOR18 Sep 2026

This makes a mockery of the the so called rules and regulations when something as blatant as this is done.It's a shame a shareholder can't propose themselves as a director just to prevent the strike-off.Is there nothing legal that can be done at this point?

Letter to Pointon Young, former auditors to Amazing AI

TOYIN18 Sep 2026

Thanks Tom, just picked some more up sub 8p.

Good news travels fast but bad news….the case of Skinbiotherapeutics

JOHN BROWN18 Sep 2026

It's outrageous that the likes of Amy Hunt claim that women with Sydney Sweeney's body shape cannot play sport. Who said that sportswomen can't look like Ms Sweeney?

Tom Winnifrith Bearcast: the Sydney Sweeney row with the Mrs and daughter 2

MICKTHELINGE18 Sep 2026

If it gets to 3p then construction will be going well and it will be well on the way to 6p+ so interested in why you would sell out then?

Reinvesting my Satsuma Winnings

TOM18 Sep 2026

Whatever Opti's intentions it will have to sell.You could say you should sell now as maybe your last chance to sell at above 8oops too late, now 7.5p to sell

Good news travels fast but bad news….the case of Skinbiotherapeutics

DUCKnDIVE18 Sep 2026

I thought that a seasoned reader of financial statements would have clocked that OPTI's HY results to 30/6/26 classed their SBTX shares as non-current assets – meaning that management has no intention to sell them within 12 months.Maybe you assumed that they were forced to class them as non-current because SBTX shares were suspended…but no, the SBTX suspension was lifted weeks before OPTI's sign-off date.And if you believe that OPTI haven't sold all or most of their remaining SBTX shares since June 30th, I'm afraid they saw you coming.There is of course a risk that OPTI has double accounted for its SBTX shares, having included them in both non-current assets and in "cash and equivalents", which might be a fruitful line of enquiry for you.As for Skin's RNS arriving a day outside the standard 10th-20th definition of mid-month, they have had a lot of balls to juggle so a 24hr delay ought to be a cause for congratulations.Why not grab some SBTX shares this afternoon? Could be your last chance to buy back below 12p.

Good news travels fast but bad news….the case of Skinbiotherapeutics

DUCKnDIVE18 Sep 2026

Notwithstanding your ad nauseam negativity on SBTX, I choose to believe the positive indications from the 8 June RNS, including "Growth continued across the company", under Current Trading and Outlook (from a chairman who never speaks with forked tongue). Accordingly, I have helped myself to a nice top-up in anticipation of a welcome trading update on Monday.

Tom Winnifrith Bearcast: Hang on for the PS in the podcast

BOBINS18 Sep 2026

lets hope the Houthis keep away from the Saudi Mines?

Reinvesting my Satsuma Winnings